These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Scleroderma and porphyria cutanea tarda]. Tsukazaki N, Okada S, Yoshida H. Nihon Rinsho; 1995 Jun; 53(6):1463-7. PubMed ID: 7616663 [Abstract] [Full Text] [Related]
6. The significance of histologic analysis of skin lesions in porphyria cutanea tarda. Light microscopy, electron microscopy, immunohistochemical and immunofluorescence analysis. Krajnc I, Vizjak A, Hvala A, Jurcić V, Rozman B. Wien Klin Wochenschr; 1998 Oct 02; 110(18):651-4. PubMed ID: 9816639 [Abstract] [Full Text] [Related]
10. Management of porphyria cutanea tarda in the setting of chronic renal failure: a case report and review. Shieh S, Cohen JL, Lim HW. J Am Acad Dermatol; 2000 Apr 02; 42(4):645-52. PubMed ID: 10727312 [Abstract] [Full Text] [Related]
11. Porphyria cutanea tarda symptomatica (PCT-S). A study of the effect of phlebotomy therapy. Epstein JH, Redeker AG. Arch Dermatol; 1965 Sep 02; 92(3):286-9; discussion 289-90. PubMed ID: 11851252 [Abstract] [Full Text] [Related]
15. Scarring alopecia and sclerodermatous changes of the scalp in a patient with hepatitis C infection. Jackson JM, Callen JP. J Am Acad Dermatol; 1998 Nov 02; 39(5 Pt 2):824-6. PubMed ID: 9810907 [Abstract] [Full Text] [Related]